The estimated Net Worth of Iii Thomas F Zenty is at least 4.85 千$ dollars as of 3 April 2019. Iii Zenty owns over 3,025 units of Endologix stock worth over 4,852$ and over the last 12 years Iii sold ELGX stock worth over 0$.
Sign up
Iii Zenty ELGX stock SEC Form 4 insiders trading
Iii has made over 4 trades of the Endologix stock since 2016, according to the Form 4 filled with the SEC. Most recently Iii bought 3,025 units of ELGX stock worth 19,995$ on 3 April 2019.
The largest trade Iii's ever made was buying 5,000 units of Endologix stock on 22 May 2017 worth over 22,200$. On average, Iii trades about 1,169 units every 72 days since 2013. As of 3 April 2019 Iii still owns at least 22,053 units of Endologix stock.
You can see the complete history of Iii Zenty stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Iii Zenty's mailing address?
Iii's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Insiders trading at Endologix
Over the last 21 years, insiders at Endologix have traded over 72,068,611$ worth of Endologix stock and bought 306,824 units worth 2,023,811$ . The most active insiders traders include International, L.P. Elliott、Associates, L.P. Elliott、Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of 13,088$. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth 2,592$.
What does Endologix do?
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
What does Endologix's logo look like?
Complete history of Iii Zenty stock trades at Endologix
Endologix executives and stock owners
Endologix executives and other stock owners filed with the SEC include:
-
Dan Lemaitre,
Director -
Leslie V Norwalk,
Director -
David M. Jennings,
VP-Human Resources -
Iii Thomas F Zenty,
Director -
Gregory D Waller,
Director -
Michael V. Chobotov,
Chief Technology Officer -
Amanda L. De Palma,
VP, Global Marketing -
John D Mc Dermott,
Chief Executive Officer -
Christopher G. Chavez,
Director -
James Edward Machek,
VP-Research & Development -
Shari L O'quinn,
VP, Clinical & Regulatory -
Thomas Wilder,
Director -
Guido J Neels,
Director -
Jose A. Lima,
VP-Quality -
Joseph A. De John,
General Manager, Asia & Pac -
Jeremy B. Hayden,
General Counsel -
Matthew Thompson,
Chief Medical Officer -
Laura Nagel,
VP, Quality -
Stefan Schreck,
Vice President -
Vaseem Mahboob,
Chief Financial Officer -
Jeffrey F Odonnell,
Director -
Capital Management Lp Camber,
-
International, L.P. Elliott,
10% owner -
Leonard M. Greenstein,
VP Finance & Corp Controller -
Greef Roderick De,
Director -
Robert D Mitchell,
President -
Martin Tyler,
V.P. Global Marketing -
Franklin D Brown,
Executive Chairman -
Woodlands Health Ventures F...,
10% owner -
Paul Mccormick,
Chief Executive Officer & Pres -
Associates, L.P. Elliott,
10% owner -
Edward Diethrich,
Director -
Daniel Hawkins,
Vice Pres - Global Marketing -
Todd Abraham,
VP of Operations -
Janet Mary Fauls,
Vice President RA/QA/QC -
Charles Steele Love,
VP-Clinical Affairs -
Shelley B Thunen,
Chief Financial Officer -
Cecile Ferracci,
General Manager, Europe -
Ronald H Coelyn,
Director -
John Onopchenko,
CEO and Director -
Karen Uyesugi,
Vice President -
Robert John Krist,
Chief Financial Officer -
Ruth Anne Lyons,
VP Global Marketing -
Gary I. Sorsher,
Vice President - Quality -
Joseph A Bishop,
Vice President Research & Devl -
Jeffrey H Thiel,
Director -
Maurice Buchbinder,
Director -
Herbert H Mertens,
Vice President of Sales/Mktg -
Michael R Henson,
Director -
David M Richards,
Chief Financial Officer & Secr -
John Zehren,
Chief Commercial Officer -
Jeff Fecho,
Chief Quality Officer -
Jane E Kiernan,
Director -
Cynthia Buch Pinto,
Interim CFO -
Timothy Nicholas Brady,
Controller and Corp Secretary